What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
GWTRONIC Intent to Use Trademark Application for Electronics
The USPTO has received an intent-to-use trademark application from GWTRONIC for various consumer electronic products. The application, filed on March 22, 2026, covers items such as audio amplifiers, speakers, cables, and power conversion devices.
USPTO Trademark Application: KADDY+ Disc Golf App
The USPTO has received an intent-to-use trademark application for 'KADDY+' for a downloadable mobile application related to disc golf. The application covers software for scoring, performance tracking, course mapping, and gameplay management.
5O. COM Trademark Application Published for Opposition
The USPTO has published the trademark application for '5O. COM' for opposition. The application, filed on March 22, 2026, covers a range of computing and electronics goods, including antennas, amplifiers, integrated circuits, and transceivers. This publication opens a period for third parties to oppose the registration.
USPTO Trademark Application for Primepet Looks AI Image Software
The USPTO has received an intent-to-use trademark application from Primepet Looks for AI image software. The application covers SaaS and downloadable software for generating, editing, and enhancing digital images, particularly of pets, using artificial intelligence.
USPTO Trademark Application Published for Opposition
The USPTO has published a trademark application for opposition concerning downloadable software for tracking travel and visa compliance in the Schengen Area. The application was published on March 23, 2026, with a filing date of March 22, 2026.
DAYSTEPS SAAS Trademark Application
The USPTO has received an intent-to-use trademark application from DAYSTEPS for SAAS services and downloadable software. The application covers software designed to assist individuals, including those with ADHD, autism, and executive function challenges, in managing daily routines and facilitating care coordination.
XINFORG trademark application published for opposition
XINFORG trademark application published for opposition
USPTO Patent Grant for LRP6 Protein Binding Antibodies
The USPTO has granted a patent (US12583919B2) to Antlera Therapeutics Inc. for antibodies that specifically bind to LRP6 proteins and methods of their use. The patent was filed on August 14, 2020, and is set to be granted on March 24, 2026.
USPTO Patent US12583917B2: IL17A Antibodies for Veterinary Use
The USPTO has granted patent US12583917B2 to Elanco US Inc. for IL17A antibodies and antagonists intended for treating conditions in animals, including companion animals. The patent details specific antibody embodiments and IgG Fc variant polypeptides designed to reduce immune responses.
USPTO Patent Grant for Cancer Diagnosis using Anti-BAG2 Antibody
The USPTO has granted a patent (US12583915B2) to Medpacto, Inc. for methods of diagnosing cancer using an anti-BAG2 antibody. The patent covers compositions comprising antibodies that specifically bind to BAG2 polypeptides or fragments thereof.
Browse by country
United States
1682 sources
United Kingdom
82 sources
European Union
74 sources
International
31 sources
Canada
30 sources
Australia
22 sources
Singapore
17 sources
France
11 sources
India
10 sources
Italy
8 sources
Hong Kong
6 sources
Switzerland
5 sources
Germany
5 sources
Poland
5 sources
New Zealand
4 sources
Ireland
3 sources
Japan
3 sources
Luxembourg
3 sources
GH
3 sources
NG
3 sources
South Korea
2 sources
KE
2 sources
MT
2 sources
South Africa
2 sources
CY
2 sources
Austria
2 sources
UAE
2 sources
Hungary
1 sources
Croatia
1 sources
Greece
1 sources
GI
1 sources
GG
1 sources
Finland
1 sources
Netherlands
1 sources
Norway
1 sources
Spain
1 sources
DK
1 sources
Romania
1 sources
Uganda
1 sources
Browse by category
Courts & Legal
323 sources
Government & Legislation
261 sources
Banking & Finance
236 sources
Healthcare
131 sources
Trade & Sanctions
124 sources
Labor & Employment
111 sources
Energy
104 sources
Pharma & Drug Safety
99 sources
Environment
83 sources
Securities & Markets
79 sources
Data Privacy & Cybersecurity
64 sources
Tax
64 sources
Agriculture & Food Safety
61 sources
Transportation
56 sources
Insurance
56 sources
Defense & National Security
48 sources
Telecom & Technology
47 sources
Consumer Protection
40 sources
Education
20 sources
Housing
16 sources
Immigration
9 sources
Legal & Courts
1 sources
Browse by agency
EDPB
4 sources
STB
3 sources
NSF
3 sources
EMA
3 sources
AHRQ
3 sources
EU Council
3 sources
VA Courts
3 sources
FEC
3 sources
HUD
3 sources
DOC
3 sources
CIPO
3 sources
ASIC
3 sources
State Pharmacy
3 sources
BaFin
3 sources
ACPR
3 sources
CRB
3 sources
DOI
3 sources
WA Courts
3 sources
NCSC
3 sources
SAMHSA
3 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.